News
Morgan Stanley raised the firm’s price target on Humana (HUM) to $290 from $285 and keeps an Equal Weight rating on the shares. While policy ...
UnitedHealth (UNH) stock and Alignment Healthcare (ALHC) stock wins top picks at Baird, which says managed care is a “tariff ...
Barclays analyst Andrew Mok CFA maintained a Buy rating on Radnet (RDNT – Research Report) today and set a price target of $60.00.Stay Ahead of ...
UnitedHealth Group is seen as the pacesetter for Medicare Advantage, but some analysts view its poor first quarter as an ...
The rise of Medicare Advantage plans offers seniors new choices within the complex framework of Medicare options. From personalized care preferences to expanded benefits, more than half of ...
UnitedHealth Group cut its earnings guidance after reporting higher-than-expected care costs in its Medicare Advantage ...
Humana is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 Humana has on average reported free cash flows of $3.16 Billion over the last four years, ...
According to Humana, CMS miscalculated its scores, which spelled bad news for the company's finances because higher star ...
Humana (NYSE:HUM) loses an administrative appeal filed in response to its 2025 Medicare Star Ratings cut. Read more here.
The decision, which Humana disclosed in a Tuesday filing with the court overseeing its lawsuit against the HHS, will be ...
CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $60.67, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results